BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 37965331)

  • 1. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
    Qu J; Li P; Sun Z
    Front Immunol; 2023; 14():1284344. PubMed ID: 37965331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
    Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination.
    Wang JH; Mao L; Wang J; Zhang X; Wu M; Wen Q; Yu SC
    Cell Oncol (Dordr); 2023 Jun; 46(3):465-480. PubMed ID: 36656507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone lactylation: from tumor lactate metabolism to epigenetic regulation.
    Yu X; Yang J; Xu J; Pan H; Wang W; Yu X; Shi S
    Int J Biol Sci; 2024; 20(5):1833-1854. PubMed ID: 38481814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crosstalking of lactate-Histone lactylation and tumor.
    Rong Y; Dong F; Zhang G; Tang M; Zhao X; Zhang Y; Tao P; Cai H
    Proteomics Clin Appl; 2023 Sep; 17(5):e2200102. PubMed ID: 36853081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer.
    Wang T; Ye Z; Li Z; Jing DS; Fan GX; Liu MQ; Zhuo QF; Ji SR; Yu XJ; Xu XW; Qin Y
    Cell Prolif; 2023 Oct; 56(10):e13478. PubMed ID: 37060186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects.
    Chen AN; Luo Y; Yang YH; Fu JT; Geng XM; Shi JP; Yang J
    Front Immunol; 2021; 12():688910. PubMed ID: 34177945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate and lactylation: Behind the development of tumors.
    Dai E; Wang W; Li Y; Ye D; Li Y
    Cancer Lett; 2024 Jun; 591():216896. PubMed ID: 38641309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactate, histone lactylation and cancer hallmarks.
    Lv X; Lv Y; Dai X
    Expert Rev Mol Med; 2023 Jan; 25():e7. PubMed ID: 36621008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate and Lactylation in the Brain: Current Progress and Perspectives.
    Li R; Yang Y; Wang H; Zhang T; Duan F; Wu K; Yang S; Xu K; Jiang X; Sun X
    Cell Mol Neurobiol; 2023 Aug; 43(6):2541-2555. PubMed ID: 36928470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactylation: novel epigenetic regulatory and therapeutic opportunities.
    Fan H; Yang F; Xiao Z; Luo H; Chen H; Chen Z; Liu Q; Xiao Y
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E330-E338. PubMed ID: 36856188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells.
    Pan L; Feng F; Wu J; Fan S; Han J; Wang S; Yang L; Liu W; Wang C; Xu K
    Pharmacol Res; 2022 Jul; 181():106270. PubMed ID: 35605812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactylation: the novel histone modification influence on gene expression, protein function, and disease.
    Hu Y; He Z; Li Z; Wang Y; Wu N; Sun H; Zhou Z; Hu Q; Cong X
    Clin Epigenetics; 2024 May; 16(1):72. PubMed ID: 38812044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges.
    Liu X; Zhang Y; Li W; Zhou X
    Front Cell Dev Biol; 2022; 10():972020. PubMed ID: 36092712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription.
    Zhang Y; Song H; Li M; Lu P
    Clin Transl Med; 2024 Mar; 14(3):e1614. PubMed ID: 38456209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate-induced histone lactylation by p300 promotes osteoblast differentiation.
    Minami E; Sasa K; Yamada A; Kawai R; Yoshida H; Nakano H; Maki K; Kamijo R
    PLoS One; 2023; 18(12):e0293676. PubMed ID: 38051708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Action of Lactic Acid on Histones in Cancer.
    Sgarra R; Battista S; Cerchia L; Manfioletti G; Fedele M
    Antioxid Redox Signal; 2024 Feb; 40(4-6):236-249. PubMed ID: 36851901
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.
    Li W; Zhou C; Yu L; Hou Z; Liu H; Kong L; Xu Y; He J; Lan J; Ou Q; Fang Y; Lu Z; Wu X; Pan Z; Peng J; Lin J
    Autophagy; 2024 Jan; 20(1):114-130. PubMed ID: 37615625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic regulation of gene expression by histone lactylation.
    Zhang D; Tang Z; Huang H; Zhou G; Cui C; Weng Y; Liu W; Kim S; Lee S; Perez-Neut M; Ding J; Czyz D; Hu R; Ye Z; He M; Zheng YG; Shuman HA; Dai L; Ren B; Roeder RG; Becker L; Zhao Y
    Nature; 2019 Oct; 574(7779):575-580. PubMed ID: 31645732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer.
    Xie B; Lin J; Chen X; Zhou X; Zhang Y; Fan M; Xiang J; He N; Hu Z; Wang F
    Mol Cancer; 2023 Sep; 22(1):151. PubMed ID: 37684641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.